Arterial Remodeling Technologies Discloses Data From In Vivo Study That Its Stent’s Biodegradability Is Quantifiable While Preserving Its Mechanical Strength And Causing Almost No Vessel Inflammation

PARIS--(BUSINESS WIRE)--Arterial Remodeling Technologies (“ART”) disclosed today the results of an in vivo study of 48 porcine arteries implanted with its biodegradable stent. The study demonstrated that (1) the ART stent’s biodegradation is measurable and begins at the first day of implant; (2) that the ART stent retains high radial strength, thus maintaining its structural integrity during biodegradation; and, (3) that the ART stent causes virtually no inflammation of the blood vessel wall.